GLS and neoplasm: GLS inhibitors including BPTES (bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide) and CB-839 have also been demonstrated to suppress tumor growth in liver and breast cancer mouse models [177,178].